APA

Kollareddy M., Sherrard A., Park J. H., Szemes M., Gallacher K., Melegh Z., Oltean S., Michaelis M., Cinatl J., Kaidi A. & Malik K. (20170926). The small molecule inhibitor YK-4-279 disrupts mitotic progression of neuroblastoma cells, overcomes drug resistance and synergizes with inhibitors of mitosis. : Cancer letters.

Chicago

Kollareddy Madhu, Sherrard Alice, Park Ji Hyun, Szemes Marianna, Gallacher Kelli, Melegh Zsombor, Oltean Sebastian, Michaelis Martin, Cinatl Jindrich, Kaidi Abderrahmane and Malik Karim. 20170926. The small molecule inhibitor YK-4-279 disrupts mitotic progression of neuroblastoma cells, overcomes drug resistance and synergizes with inhibitors of mitosis. : Cancer letters.

Harvard

Kollareddy M., Sherrard A., Park J. H., Szemes M., Gallacher K., Melegh Z., Oltean S., Michaelis M., Cinatl J., Kaidi A. and Malik K. (20170926). The small molecule inhibitor YK-4-279 disrupts mitotic progression of neuroblastoma cells, overcomes drug resistance and synergizes with inhibitors of mitosis. : Cancer letters.

MLA

Kollareddy Madhu, Sherrard Alice, Park Ji Hyun, Szemes Marianna, Gallacher Kelli, Melegh Zsombor, Oltean Sebastian, Michaelis Martin, Cinatl Jindrich, Kaidi Abderrahmane and Malik Karim. The small molecule inhibitor YK-4-279 disrupts mitotic progression of neuroblastoma cells, overcomes drug resistance and synergizes with inhibitors of mitosis. : Cancer letters. 20170926.